Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer
26 avr. 2023 15h44 HE
|
Blue Water Biotech, Inc.
CINCINNATI, April 26, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology company spanning multiple sectors, today announced the appointment of Jay...
Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®
25 avr. 2023 08h00 HE
|
Blue Water Biotech, Inc.
CINCINNATI, April 25, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology company spanning multiple sectors, today announced that Blue Water management...
Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset
20 avr. 2023 07h30 HE
|
Blue Water Vaccines Inc.
Acquisition Transforms the Company into a Broader Pharmaceutical Company Spanning Multiple Sectors Company Announces Corporate Name Change to Underscore Broader Focus Company to Host a Conference...
Veru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones
20 avr. 2023 06h45 HE
|
Veru Inc.
MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related...
Benign Prostatic Hyperplasia Treatment Market is Expected to Reach $14.1 billion | MarketsandMarkets.
22 mars 2023 09h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, March 22, 2023 (GLOBE NEWSWIRE) -- In the near future, the Benign Prostatic Hyperplasia (BPH) treatment industry is likely to see further developments and advancements in treatment options....
Benign Prostatic Hyperplasia Treatment Market Size, Share, Qualitative Analysis and Industry Growth Factors and is growing at a CAGR of 19.4% by 2029
24 août 2022 07h57 HE
|
Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed...
Benign Prostatic Hyperplasia Treatment Market to Surpass USD 17.6 Billion by 2028 | BlueWeave Consulting
03 août 2022 11h00 HE
|
BlueWeave Consulting and Research Pvt Ltd
New Delhi, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The rise in benign prostatic hyperplasia prevalence and the expanding worldwide male geriatric population are both important factors driving the growth...
Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25.41% by 2026 | DelveInsight
22 avr. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, April 22, 2021 (GLOBE NEWSWIRE) -- Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25.41% by 2026 | DelveInsightThe Benign Prostatic Hyperplasia (BPH)...
Global Disposable Incontinence Products Market Is Expected to Reach USD 18.59 billion by 2027 : Fior Markets
12 oct. 2020 22h00 HE
|
Fior Markets
Newark, NJ, Oct. 12, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global disposable incontinence products market is expected to grow from USD 10.42 billion in 2019 and...
Urinary Catheter Market To Reach USD 2.81 Billion By 2026 | Reports And Data
26 févr. 2020 11h00 HE
|
Reports and Data
New York, Feb. 26, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Urinary Catheter Market was valued at USD 1.49 billion in 2018 and is expected to reach...